Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingjing Pu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Clinical Medicine|January 28, 2026
Evaluation of the Efficacy of an Artificial Intelligence-Based Assessment and Correction System in the Rehabilitation of Patients Following Anterior Cruciate Ligament Reconstruction SurgeryTingting Zhu, Ying Huang, Jingjing Pu, et al.
Scientific Reports|July 2, 2025
Potential role of TNFRSF12A in linking glioblastoma and alzheimer's disease via shared tumour suppressor pathwaysTing Liu, Jingjing Pu, Sandra Theil, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2025
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approachesAmit Sharma, Dario Sangiolo, Antonio Rosato, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Clinical Medicine|January 28, 2026
Evaluation of the Efficacy of an Artificial Intelligence-Based Assessment and Correction System in the Rehabilitation of Patients Following Anterior Cruciate Ligament Reconstruction SurgeryTingting Zhu, Ying Huang, Jingjing Pu, et al.
Scientific Reports|July 2, 2025
Potential role of TNFRSF12A in linking glioblastoma and alzheimer's disease via shared tumour suppressor pathwaysTing Liu, Jingjing Pu, Sandra Theil, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2025
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approachesAmit Sharma, Dario Sangiolo, Antonio Rosato, et al.
Pageof 2